Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

High viral and/or antigen load may be an important cause of the T cell hyporesponsiveness to hepatitis B virus (HBV) antigens that is often observed in patients with chronic HBV infection. Reduction of viral and antigen load by lamivudine treatment represents an ideal model for investigating this hy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Boni, C, Bertoletti, A, Penna, A, Cavalli, A, Pilli, M, Urbani, S, Scognamiglio, P, Boehme, R, Panebianco, R, Fiaccadori, F, Ferrari, C
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 1998
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508962/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9727065/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI3731
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados